Deferasirox

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1414 publications

Comparative Study of Ferritin Levels between Two Generic Formulations of Deferasirox in Sri Lankan Patients with Beta-Thalassemia Major.

Comparative Study of Ferritin Levels between Two Generic Formulations of Deferasirox in Sri Lankan Patients with Beta-Thalassemia Major.

Journal: Hemoglobin

Published: April 07, 2026

Successful Outcome of Rhino-Orbital-Cerebral Mucormycosis With Extensive Intracranial Disease in a Patient With Poorly Controlled Diabetes.

Successful Outcome of Rhino-Orbital-Cerebral Mucormycosis With Extensive Intracranial Disease in a Patient With Poorly Controlled Diabetes.

Journal: The Permanente journal

Published: March 23, 2026

Transfusion-Related Iron Overload in Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Addressing an Overlooked Treatment Complication.

Transfusion-Related Iron Overload in Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Addressing an Overlooked Treatment Complication.

Journal: Cureus

Published: February 09, 2026

Mitochondria-targeted carbon monoxide delivery combined with iron chelation therapy for cancer synergistic treatment.

Mitochondria-targeted carbon monoxide delivery combined with iron chelation therapy for cancer synergistic treatment.

Journal: Colloids and surfaces. B, Biointerfaces

Published: February 05, 2026

Treatment of pulmonary mucormycosis: current concepts.

Treatment of pulmonary mucormycosis: current concepts.

Journal: Expert review of anti-infective therapy

Published: January 23, 2026

Impact of Vitamin E, Selenium, and Deferasirox on the Negative Effects of Experimental Coccidiosis.

Impact of Vitamin E, Selenium, and Deferasirox on the Negative Effects of Experimental Coccidiosis.

Journal: Biological trace element research

Published: December 29, 2025

Modular Design of Mitochondrion-Targeted Iron Chelators Allows Highly Selective Antiparasitic Activity against Trypanosomes and Apicomplexan Parasites.

Modular Design of Mitochondrion-Targeted Iron Chelators Allows Highly Selective Antiparasitic Activity against Trypanosomes and Apicomplexan Parasites.

Journal: ACS infectious diseases

Published: December 22, 2025

A Cross-Sectional Study on Pain and Quality of Life of Adult Patients with Transfusion-Dependent Thalassemia in a Tertiary Hospital In Malaysia.

A Cross-Sectional Study on Pain and Quality of Life of Adult Patients with Transfusion-Dependent Thalassemia in a Tertiary Hospital In Malaysia.

Journal: Hemoglobin

Published: December 11, 2025

Association Between Iron Overload and Glucose Metabolism in Children and Youth with Transfusion-Dependent Beta Thalassemia: The Role of Chelation Therapy.

Association Between Iron Overload and Glucose Metabolism in Children and Youth with Transfusion-Dependent Beta Thalassemia: The Role of Chelation Therapy.

Journal: Mediterranean journal of hematology and infectious diseases

Published: December 10, 2025

Targeted delivery and controlled release of deferasirox for melanoma therapy.

Targeted delivery and controlled release of deferasirox for melanoma therapy.

Journal: iScience

Published: November 21, 2025

Targeting Aging and Diseases Associated with Ferroptosis and Senescence Through Modulation of Iron, Oxidative Stress and Lipid Peroxidation.

Targeting Aging and Diseases Associated with Ferroptosis and Senescence Through Modulation of Iron, Oxidative Stress and Lipid Peroxidation.

Journal: Antioxidants (Basel, Switzerland)

Published: November 20, 2025

Effect of Deferasirox Six Months after allo-HSCT on AML/MDS Outcomes: a Propensity-Score Matched Study.

Effect of Deferasirox Six Months after allo-HSCT on AML/MDS Outcomes: a Propensity-Score Matched Study.

Journal: Blood advances

Published: October 27, 2025

Showing 1-12 of 1,414

Last Updated: 04/28/2026